Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Phase 2 randomized, dose-ranging trial of CTP-543, a sele... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata
2
Authors
Brett King
11 more
Brett King
•
Natasha Mesinkovska
9 more
•
James Cassella
Published
August 1, 2022
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of the American Academy of Dermatology
Topics
Medicine
Clinical Trials
Immunology
Pathology
Dermatology
Show all topics
DOI
10.1016/j.jaad.2022.03.045
License
CC-BY-NC-ND
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of the American Academy of Dermatology
Topics
Medicine
Clinical Trials
Immunology
Pathology
Dermatology
Show all topics
DOI
10.1016/j.jaad.2022.03.045
License
CC-BY-NC-ND
